T
Tikun Olam Cannbit Pharmaceuticals Ltd
TASE:TKUN
Tikun Olam Cannbit Pharmaceuticals Ltd
TASE:TKUN
Price:
2 132
ILS
-1.43%
Market Closed
Market Cap:
₪18.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Tikun Olam Cannbit Pharmaceuticals Ltd
Net Income (Common)
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Tikun Olam Cannbit Pharmaceuticals Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Tikun Olam Cannbit Pharmaceuticals Ltd
TASE:TKUN
|
Net Income (Common)
-₪25.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Net Income (Common)
$1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
|
|
Sol Gel Technologies Ltd
NASDAQ:SLGL
|
Net Income (Common)
-$6.1m
|
CAGR 3-Years
26%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
PolyPid Ltd
NASDAQ:PYPD
|
Net Income (Common)
-$34.2m
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Net Income (Common)
-$23.9m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-1%
|
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Net Income (Common)
-₪18.1m
|
CAGR 3-Years
-107%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Tikun Olam Cannbit Pharmaceuticals Ltd
Glance View
Tikun Olam-Cannbit Pharmaceuticals Ltd. engages in the cultivation and marketing of medical cannabis. The firm engages in growing and cultivating medical cannabis products.
TKUN
Intrinsic Value
3 131.02
ILS
Undervaluation 32%
T
See Also
What is Tikun Olam Cannbit Pharmaceuticals Ltd's Net Income (Common)?
Net Income (Common)
-25.8m
ILS
-25.8m
ILS
Based on the financial report for Jun 30, 2025, Tikun Olam Cannbit Pharmaceuticals Ltd's Net Income (Common) amounts to -25.8m ILS.
What is Tikun Olam Cannbit Pharmaceuticals Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-5%
-5%
Over the last year, the Net Income (Common) growth was 48%. The average annual Net Income (Common) growth rates for Tikun Olam Cannbit Pharmaceuticals Ltd have been 1% over the past three years , -5% over the past five years .
